Polymorphisms in the SAA1/2 gene are associated with carotid intima media thickness in healthy han chinese subjects: The cardiovascular risk survey

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Xie, Xiang ^a,b   Ma, Yi Tong ^a,b   Yang, Yi Ning ^a,b   Fu, Zhen Yan ^a,b   Li, Xiao Mei ^a,b   Huang, Ding ^a   Ma, Xiang ^a,b   Chen, Bang Dang ^b   Liu, Fen ^b  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b Xinjiang Key Laboratory of Cardiovascular Disease Research   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; SERUM AMYLOID A; SERUM AMYLOID A1 PROTEIN; SERUM AMYLOID A2 PROTEIN; UNCLASSIFIED DRUG; SAA1 PROTEIN, HUMAN; SAA2 PROTEIN, HUMAN;

ADULT; ARTERIAL WALL THICKNESS; ARTERY INTIMA PROLIFERATION; ARTICLE; B SCAN; CARDIOVASCULAR RISK; CAROTID ARTERY; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEALTH SURVEY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; BLOOD; CARDIOVASCULAR DISEASE; CHINA; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HISTOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; RISK FACTOR; STATISTICAL MODEL; TUNICA MEDIA;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEALTH SURVEYS; HUMANS; LINEAR MODELS; LINKAGE DISEQUILIBRIUM; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SERUM AMYLOID A PROTEIN; TUNICA MEDIA;

EID: 78649513112     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013997     Document Type: Article

References (30)

1. Uhlar CM, Whitehead AS (1999) Serum amyloid A. The major vertebrate acute-phase reactant. Eur J Biochem 265: 501-523.
2. Kirwan J, Edwards A, Huitfeldt B, Thompson P, Currey H (1993) The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years. Br J Rheumatol 32: 729-733.
3. Scalapino KJ, Davis JC, Jr. (2003) The treatment of ankylosing spondylitis. Clin Exp Med 2: 159-165.
4. Schillinger M, Exner M, Mlekusch W, Ssbeti S, Amighi J, et al. (2005) Inflammation and carotid Artery - Risk for Atherosclerosis study (ICATAS). Circulation 111: 2203-2209.
5. Fyfe AI, Rothenberg LS, de Beer FC, Cantor RM, Rotter JI, et al. (1997) Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation 96: 2914-2919.
6. Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, et al. (2004) National Heart, Lung, and Blood Institute. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrom Evaluation (WISE): Circulation 109: 726-732.
7. Moriguchi M, Terai C, Kaneko H, Koseki Y, Kajiyama H, et al. (2001) A novel single-nucleotide polymorphism at the 59-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis. Arth Rheum 44: 1266-1272.
8. Carty CL, Heagerty P, Heckbert SR, Enquobahrie DA, Jarvik GP, Davis S, Tracy RP, Reiner AP, et al. (2009) Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1band TNF gene in the cardiovascular health study. J Ather Throm 16: 419-430.
9. Malle E, De Beer FC (1996) Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest 26: 427-435.
10. Benditt EP, Eriksen N, Hermodson MA, Ericsson LH (1971) The major proteins of human and monkey amyloid substance: common properties including unusual N-terminal amino acid sequences. FEBS Lett 19: 169-173.
11. Levin M, Franklin EC, Frangione B, Pras M (1972) The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest 51: 2773-2776.
12. Benditt EP, Eriksen N (1977) Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci USA 74: 4025-4028.
13. Benditt EP, Eriksen N, Hanson RH (1979) Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein. Proc Natl Acad Sci USA 76: 4092-4096.
14. Benditt EP, Hoffman JS, Eriksen N, Parmelee DC, Walsh KA (1982) SAA, an apoprotein of HDL: its structure and function. Ann N Y Acad Sci 389: 183-189.
15. Clifton PM, Mackinnon AM, Barter PJ (1985) Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction. J Lipid Res 26: 1389-1398.
16. Coetzee GA, Strachan AF, van der Westhuyzen DR, Hoppe HC, Jeenah MS, et al. (1986) Serum amyloid A-containing human high density lipoprotein 3: Density, size, and apolipoprotein composition. J Biol Chem 261: 9644-9651.
17. Graversen JH, Castro G, Kandussi A, Nielsen H, Christensen EI, et al. (2008) A pivital role of the human kidney in catabolism of HDL. Protein components apolipoprotein A-I and A-IV but not of A-II. Lipids 43: 467-470.
18. Lowell CA, Stearman RS, Morrow JF (1986) Transcriptional regulation of serum amyloid A gene expression. J Biol Chem 261: 8453-8461.
19. Navarro MA, Carpintero R, Acin S, Arbones-Mainar JM, Calleja L, et al. (2005) Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation. Cytokine 31: 52-63.
20. O'Brien KD, McDonald TO, Kunjathoor V, Eng KL, Knopp EA, et al. (2005) Serum amyloid A and lipoprotein retention in murine models of atherosclerosis. Arterioscler Thromb Vasc Biol 25: 785-790.
21. Liao YC, Lin HF, Guo YC, Yu ML, Liu CK, et al. (2010) Sex-differential genetic effect of phosphodiesterase 4D (PDE4D) on carotid atherosclerosis. BMC Medical Genetics 11: 93-102.
22. Yamada T, Wada A, Itoh Y, Itoh K (1999) Serum amyloid A1 alleles and plasma SAA concentration. Amyloid 6: 199-204.
23. Hayat S, Raynes JG (2000) Acute phase serum amyloid A protein increases high density lipoprotein binding to human peripheral blood mononuclear cells and an endothelial cell line. Scand J Immunol 51: 141-146.
24. Artl A, Marsche G, Lestavel S, Sattler W, Malle E (2000) Role of serum amyloid A during metabolism of acute-phase HDL by macrophages. Arterioscler Thromb Vasc Biol 20: 763-772.
25. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, et al. (2007) A ''silent'' polymorphism in the MDR1 gene changes substrate specificity. Science 318: 1382-1383.
26. Patel S, Flyvbjerg A, Kozàkovà M, Frystyk J, Ibrahim IM, et al. (2008) Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. Eur Heart J 29: 386-393.
27. Xie X, Ma YT, Fu ZY, Yang YN, Ma X, et al. (2009) Haplotype Analysis of the CYP8A1 gene associated with myocardial infarction. Clin Appl Thromb-Hem 15: 574-580.
28. Xie X, Ma YT, Fu ZY, Yang YN, Ma X, et al. (2009) Association of polymorphisms of PTGS2 and CYP8A1 with myocardial infarction. Clin Chem Lab Med 47: 347-352.
29. Lee YH, Shin MH, Kweon SS, Choi SW, Kim HY, et al. (2009) Alcohol consumption and carotid artery structure in Korean adults aged 50 years and older. BMC Public Health 9: 358-364.
30. Liu G, Wang Y, Wong L (2010) FastTagger: an efficient algorithm for genomewide tag SNP selection using multi-marker linkage disequilibrium. BMC Bioinformatics 11: 66.